Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › BQC-G, a tumor-selective anti-cancer prodrug

BQC-G, a tumor-selective anti-cancer prodrug

US Patent 9353140 · Granted May 31, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Esterification/saponification-based method for liposomal encapsulation of hydrop2021
Immunogenic peptide containing a b cell epitope of tumor associated antigen L62021
Multi-drug delivery system and uses thereof2021
Engineered enzyme for enzyme replacement therapy2020
Multi-drug delivery system and use thereof2020
Method for detecting protein by using secondary antibody detected epitope tag2019
Secondary antibody detected epitope and preparation of same2016
Recombinant nucleotide sequence, cell or vector containing the same and method f2013
Human beta-glucuronidase mutants with elevated enzymatic activity under physiolo2013
Human beta-glucuronidase mutants with elevated enzymatic activity under physiolo2013
Monoclonal antibody for analysis and clearance of polyethylene glycol and polyet2008
Chimeric protein and method of controlling tumor growth using the protein2004